Participation of women in clinical trials supporting FDA approval of cardiovascular drugs PE Scott, EF Unger, MR Jenkins, MR Southworth, TY McDowell, RJ Geller, ... Journal of the American College of Cardiology 71 (18), 1960-1969, 2018 | 303 | 2018 |
Speaker introductions at internal medicine grand rounds: forms of address reveal gender bias JA Files, AP Mayer, MG Ko, P Friedrich, M Jenkins, MJ Bryan, S Vegunta, ... Journal of women's health 26 (5), 413-419, 2017 | 289 | 2017 |
Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the Women’s Heart Alliance CN Bairey Merz, H Andersen, E Sprague, A Burns, M Keida, MN Walsh, ... Journal of the American College of Cardiology 70 (2), 123-132, 2017 | 253 | 2017 |
Nanotechnology and human health: risks and benefits AG Cattaneo, R Gornati, E Sabbioni, M Chiriva‐Internati, E Cobos, ... Journal of applied Toxicology 30 (8), 730-744, 2010 | 186 | 2010 |
Fruits and dietary phytochemicals in bone protection CL Shen, V von Bergen, MC Chyu, MR Jenkins, H Mo, CH Chen, IS Kwun Nutrition Research 32 (12), 897-910, 2012 | 149 | 2012 |
Embedding concepts of sex and gender health differences into medical curricula VM Miller, M Rice, L Schiebinger, MR Jenkins, J Werbinski, A Núnez, ... Journal of Women's Health 22 (3), 194-202, 2013 | 127 | 2013 |
Galectins in cancer: carcinogenesis, diagnosis and therapy AH Ebrahim, Z Alalawi, L Mirandola, R Rakhshanda, S Dahlbeck, ... Annals of translational medicine 2 (9), 2014 | 125 | 2014 |
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy JA Figueroa, A Reidy, L Mirandola, K Trotter, N Suvorava, A Figueroa, ... International reviews of immunology 34 (2), 154-187, 2015 | 102 | 2015 |
Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line‐specific apoptotic mechanisms PS Rao, A Satelli, M Moridani, M Jenkins, US Rao International journal of cancer 130 (11), 2703-2714, 2012 | 92 | 2012 |
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer L Mirandola, M J. Cannon, E Cobos, G Bernardini, MR Jenkins, WM Kast, ... International reviews of immunology 30 (2-3), 127-137, 2011 | 84 | 2011 |
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma L Mirandola, Y Yu, K Chui, MR Jenkins, E Cobos, CM John, ... PloS one 6 (7), e21811, 2011 | 78 | 2011 |
Effects of sex and gender on adaptations to space: reproductive health AE Ronca, ES Baker, TG Bavendam, KD Beck, VM Miller, JS Tash, ... Journal of women's health 23 (11), 967-974, 2014 | 71 | 2014 |
The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review C Cobos, JA Figueroa, L Mirandola, M Colombo, G Summers, A Figueroa, ... International reviews of immunology 33 (5), 383-401, 2014 | 65 | 2014 |
Sex and gender in medical education: a national student survey MR Jenkins, A Herrmann, A Tashjian, T Ramineni, R Ramakrishnan, ... Biology of Sex Differences 7, 25-35, 2016 | 63 | 2016 |
Sperm protein 17 is expressed in the sperm fibrous sheath M Chiriva-Internati, N Gagliano, E Donetti, F Costa, F Grizzi, ... Journal of Translational Medicine 7, 1-5, 2009 | 62 | 2009 |
AKAP‐4: A novel cancer testis antigen for multiple myeloma M Chiriva‐Internati, R Ferrari, Y Yu, C Hamrick, N Gagliano, F Grizzi, ... British journal of haematology 140 (4), 465-468, 2008 | 62 | 2008 |
Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer M Chiriva-Internati, Y Yu, L Mirandola, MR Jenkins, C Chapman, ... PloS one 5 (5), e10471, 2010 | 60 | 2010 |
Sex-and gender-based medicine: the need for precise terminology TE Madsen, G Bourjeily, M Hasnain, M Jenkins, MF Morrison, K Sandberg, ... Gender and the Genome 1 (3), 122-128, 2017 | 59 | 2017 |
Advancing sex and gender competency in medicine: sex & gender women’s health collaborative AJ McGregor, K Templeton, MR Kleinman, MR Jenkins Biology of Sex Differences 4, 1-7, 2013 | 58 | 2013 |
Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer L Mirandola, Y Yu, MJ Cannon, MR Jenkins, RL Rahman, DD Nguyen, ... Gynecologic oncology 135 (3), 573-579, 2014 | 57 | 2014 |